Eco-Friendly Drugs: Difficult, yet possible
Besides being patient friendly, pharmaceutical drugs and their manufacturing processes are expected to be eco-friendly as well.…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘We will launch INSTACOAT 4G at CPhI India 2014’
Suresh Pareek, Managing Director, Ideal Cures reveals his strategies and expectations from the CPhI India 2014 show, in an…
Way ahead in pharma solid dosage form coating technology
Ideal Cures has put a lot of emphasis on energy savings while launching the 4th generation tablet film coating system. An outlook…
Lipases: industrial biocatalysts for production of pharma intermediates and fine chemicals
Bhalchandra K Vaidy, and Sandeep Bijamwar in this article describes applications of lipases in pharma and fine chemical industry
…
Synokem Pharmaceuticals: One-point contact for every need
Synokem Pharmaceuticals is a professionally managed fast growing pharmaceutical company having over three decades of…
8th Indo-US TPF ends with work plans for continued engagement
Both sides committed to identify ways in which trade, innovation policies can enhance access to quality health and affordable…
Cipla appoints Punita Lal and Dr Nachiket Mor as Independent Directors on its Board
Lal will focus on advisory roles and Mor will concentrate in areas of financial access and healthcare
Cipla has appointed Punita…
Sultan-ul-Uloom College of Pharmacy celebrates National Education Day
Sultan-ul-Uloom College of Pharmacy in Hyderabad recently celebrated the National Education Day, as a mark of respect to the Birth…
Glenmark enrols first patient for phase II trial of GBR 500
The company out licensed Vatelizumab (GBR 500) to Sanofi for all indications in 2011
Glenmark has enrolled first patient in a…
‘The government could do more, in terms of how it sees research activities’
The government is doing many positive things in the biosciences, but could do more, in terms of how it sees research activities,…